1-9 of 9
Katarina Cepo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Subcutaneous Concizumab Prophylaxis in Patients with Hemophilia A or B with Inhibitors: Efficacy and Safety Results By Hemophilia Subtype from the Phase 3 Explorer7 Trial

Melissa Frei-Jones, Katarina Cepo, Roseline d'Oiron, Ai Sim Goh, Mary Mathias, Jan Odgaard-Jensen
Journal: Blood
Blood (2022) 140 (Supplement 1): 466–468.
https://doi.org/10.1182/blood-2022-166522
Published: 2022
Journal Articles

Active Lifestyle in Patients with Hemophilia A or B with Inhibitors on Once-Daily Subcutaneous Concizumab Prophylaxis: Results from the Phase 3 explorer7 Study

Laura Villarreal Martinez, Katarina Cepo, Jannie Laursen, Jan Odgaard-Jensen, Chur-Woo You, Jerzy Windyga
Journal: Blood
Blood (2022) 140 (Supplement 1): 5634–5636.
https://doi.org/10.1182/blood-2022-167076
Published: 2022
Journal Articles

Surgeries and Diagnostic Procedures in Hemophilia Patients on Concizumab Prophylaxis: Results from the Phase 2 Explorer4 and Explorer5 Trials

Allison P. Wheeler, Gary Benson, Hermann Eichler, Sidsel Marie Tønder, Katarina Cepo, Victor Jimenez Yuste, Kaan Kavakli, Lily LL Wong, Tadashi Matsushita
Journal: Blood
Blood (2021) 138 (Supplement 1): 345.
https://doi.org/10.1182/blood-2021-148571
Published: 2021
Journal Articles

Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events

Stephanie Valer Seremetis, MD, Katarina Cepo, MD, Josephine Skovgaard Rasmussen, DVM, Trine Høyer Rose, PhD, Søren Tamer, MSc, Thomas Porstmann, PhD, Jesper Haaning, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40.
https://doi.org/10.1182/blood-2020-139563
Published: 2020
Journal Articles

Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial

Amy D Shapiro, MD, Giancarlo Castaman, MD, Katarina Cepo, MD, Sidsel Marie Tønder, MSc, Tadashi Matsushita, MD PhD, Lone Hvitfeldt Poulsen, Guy Young, MD, Silva Zupancic-Šalek, MD, Victor Jimenez Yuste, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-139910
Published: 2020
Journal Articles

Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial

Amy Shapiro, Giancarlo Castaman, MD, Katarina Cepo, Lone Hvitfeldt Poulsen, Christian Hollensen, Tadashi Matsushita, Guy Young, MD, Silva Zupancic-Salek, Victor Jimenez-Yuste
Journal: Blood
Blood (2019) 134 (Supplement_1): 1139.
https://doi.org/10.1182/blood-2019-122809
Published: 2019
Journal Articles

Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Severe Hemophilia a without Inhibitors: Results from the Phase 2 explorer5 Trial

Hermann Eichler, Pantep Angchaisuksiri, MD, Jan Astermark, MD PhD, Gary Benson, Katarina Cepo, Pratima Chowdary, MD, Ute Friedrich, PhD, Kaan Kavakli, Allison P Wheeler, MD, Johannes Oldenburg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2417.
https://doi.org/10.1182/blood-2019-122300
Published: 2019
Journal Articles

Concizumab Subcutaneous Prophylaxis Improves Health-Related Quality-of-Life Measures in Patients with Congenital Hemophilia with Inhibitors: Phase 2 Trial Results

Xin Ying Lee, Katarina Cepo, Thomas Porstmann
Journal: Blood
Blood (2019) 134 (Supplement_1): 2419.
https://doi.org/10.1182/blood-2019-122827
Published: 2019
Journal Articles

Benefit of Early Treatment with Room Temperature Stable Recombinant Activated Factor VII (rFVIIa) in Patients with Hemophilia a or B with Inhibitors: Subgroup Analysis from the Prospective, Post-Authorization, Non-Interventional SMART-7 ™ Study

Gary Benson, Hervé Chambost, Francesco Demartis, Soraya Benchikh El Fegoun, Katarina Cepo, Lene Sommer, Kaan Kavakli
Journal: Blood
Blood (2016) 128 (22): 1439.
https://doi.org/10.1182/blood.V128.22.1439.1439
Published: 2016